Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function
Abstract
Hypoxia induces transcription of a range of physiologically important genes including erythropoietin and vascular endothelial growth factor. The transcriptional activation is mediated by the hypoxia-inducible factor-1 (HIF-1), a heterodimeric member of the basic helix-loop-helix PAS family, composed of alpha and beta subunits. HIF-1alpha shares 48 per cent identity with the recently identified HIF-2alpha protein that is also stimulated by hypoxia. In a previous study of hemangioblastomas, the most frequent manifestation of hereditary von Hippel-Lindau disease (VHL), we found elevated levels of vascular endothelial growth factor and HIF-2alpha mRNA in stromal cells of the tumors. Mutations of the VHL tumor suppressor gene are associated with a variety of tumors such as renal clear cell carcinomas (RCC). In this study, we analysed the expression of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in a range of VHL wildtype and VHL deficient RCC cell lines. In the presence of functional VHL protein, HIF-1alpha mRNA levels are elevated, whereas HIF-2alpha mRNA expression is increased only in cells lacking a functional VHL gene product. On the protein levels, however, in VHL deficient cell lines, both HIF-alpha subunits are constitutively expressed, whereas re-introduction of a functional VHL gene restores the instability of HIF-1alpha and HIF-2alpha proteins under normoxic conditions. Moreover, immunohistochemical analyses of RCCs and hemangioblastomas demonstrate up-regul…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In ccRCC, VHL loss impairs degradation of HIF-α proteins, leading to HIF accumulation irrespective of oxygen levels.
“In ccRCC, VHL loss impairs degradation of HIF-α proteins, leading to HIF accumulation irrespective of oxygen levels (Gnarra et al., 1994;Krieg et al., 2000).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Krieg et al., 2000
The citation lists haven’t been fetched yet
References 37 · Cited by 396
- Authors
- Krieg, M., Haas, R., Brauch, H., Acker, T., Flamme, I., & Plate, K. H.
- Affiliations
- University of Freiburg (DE)
- Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (DE)
- University of Cologne (DE)
- Venue
- Oncogene
- Published
- 2000-11-16
- Volume
- 19
- Issue
- 48
- Pages
- 5435-5443
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1996715681
- Cited by
- 396
- References
- 37
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 21 · 2023: 9 · 2022: 19 · 2021: 9 · 2020: 15 · 2019: 12 · 2018: 10 · 2017: 14 · 2016: 9 · 2015: 18 · 2014: 11 · 2013: 23 · 2012: 16
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Renal cell carcinoma treatment
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- hypoxia-inducible factor-1α, HIF-2α, von Hippel-Lindau tumor suppressor gene, clear cell renal cell carcinoma, VHL deficiency, normoxic conditions, angiogenesis, erythropoiesis, vascular endothelial growth factor, hemangioblastoma, tumor suppressor function
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Carcinoma, Renal Cell, Cerebellum, DNA-Binding Proteins, von Hippel-Lindau Disease, Humans, Immunohistochemistry, Kidney Neoplasms, Ligases, Lymphokines, Monosaccharide Transport Proteins, Mutation, Nuclear Proteins, Oxygen, Proteins, RNA, Messenger, Transcription Factors, Tumor Cells, Cultured, Trans-Activators, Up-Regulation, Polymerase Chain Reaction, Genes, Tumor Suppressor, Endothelial Growth Factors, Hemangioblastoma, Tumor Suppressor Proteins, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Ubiquitin-Protein Ligases, Glucose Transporter Type 1, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review